Tour de France: Sky and Bradley Wiggins Reportedly Used Doping Steroids in 2012

Tour de France
Bradley Wiggins with the yellow jersey of the Tour de France 2012

A report by the British Parliament’s committee of inquiry on doping states that Sky has bypassed the anti-doping rules thanks to a drug that significantly improves the performance of its riders in 2012 when Bradley Wiggins won the Tour de France.

The report of the British Parliament is straightforward. Bradley Wiggins reportedly used powerful corticoids that improved his performance in 2012 when he won the Tour de France but also the Olympic time trial title in London. “Based on the evidence that was received by the committee, we believe that this potent corticosteroid (triamcinolone) was used to prepare Bradley Wiggins, and possibly other runners, for the Tour de France. The goal was not to treat a medical need, but to improve its weight / power ratio before the race, “he explains.

Sky immediately responded to these accusations in a statement. Of course, she denies. “The report indicates that the drugs were used by the team to improve performance. We strongly refute that. The report also includes an allegation of widespread use of triamcinolone by Team Sky riders prior to the 2012 Tour de France. Again, we strongly reject this claim. “

After the Froome affair, this is a new thorny issue for the Sky that has reigned over the cycling world for several seasons.

Leave a Reply

Notify of